.jpg)
Collaborator of Aravax, the Benaroya Research Institute, receives $5 million grant
29th January 2018, Seattle, United States of America –The Benaroya Research Institute in Seattle announced receipt of National Institute...
Jan 29, 2018
Aravax presents encouraging preliminary Phase I safety data at the first Gordon Research Conference
13th January 2018, California, United States of America – Australian biotechnology company Aravax presented preliminary data from the...
Jan 13, 2018
Aravax forms Scientific Advisory Board
9th January 2018, California, United States of America – Aravax, an Australian biotechnology company revolutionising peanut allergy...
Jan 9, 2018